Stockreport

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Achieve Life Sciences, Inc. - Common Shares  (ACHV) 
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achievelifesciences.com
PDF Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for th [Read more]